Versant Venture Management as of Dec. 31, 2023
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| RayzeBio Common Stock | 82.5 | $321M | 5.2M | 62.17 | |
| CRISPR Therapeutics Common Shares (CRSP) | 8.0 | $31M | 499k | 62.60 | |
| Repare Therapeutics Common Stock (RPTX) | 5.0 | $19M | 2.6M | 7.30 | |
| Gritstone Bio Common Stock (GRTS) | 1.9 | $7.3M | 3.6M | 2.04 | |
| Passage Bio Common Stock (PASG) | 1.3 | $5.0M | 5.0M | 1.01 | |
| Adverum Biotechnologies Common Stock | 1.0 | $3.8M | 5.1M | 0.75 | |
| Aligos Therapeutics Common Stock (ALGS) | 0.4 | $1.5M | 2.3M | 0.66 |
